Denali Therapeutics Inc. company logo
Denali Therapeutics Inc. logo

Denali Therapeutics Inc. (DNLI) Cash From Operations

Annual CFO

-$347.69M$10.30M+2.88%

Summary

Current Value
As of today, DNLI annual cash from operations is -$347.69M, up +2.88% on
Historical Performance
DNLI annual cash from operations is down -64.48% over the past 3 years, and down -129.39% over the past 5 years
All-Time High Comparison
DNLI annual cash from operations is currently -183.55% below its historical high of $416.15M set on
3-Year Low Comparison
DNLI annual cash from operations is +2.88% above its 3-year low of -$357.99M reached on
Sector Comparison
DNLI annual cash from operations is higher than 1.78% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

DNLI Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations-$347.69M+2.9%-64.5%-129.4%-2209.9%
Quarterly Cash From Operations-$107.30M-81.4%-88.1%-10000.0%
TTM Cash From Operations-$397.78M-9.7%-67.5%-173.6%
Price$16.95-20.0%-41.3%-77.1%
Annual Cash From Investing-$88.76M-135.6%-310.4%-160.1%-2798.6%
Annual Cash From Financing$484.30M+2617.8%+2403.1%+7724.0%+891.3%
Annual Free Cash Flow-$363.61M+2.0%-65.4%-114.5%-1907.3%
Annual CAPEX$15.91M+23.0%+87.2%-11.2%+419.7%
Annual Net Income-$422.77M-191.1%-45.5%-113.9%-2418.3%

Cash From Operations Highs

DNLI Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y-$244.72MN/A-42.1%
5Y$416.15MN/A-183.6%
All$416.15M-183.6%

Cash From Operations Lows

DNLI Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y-$357.99M+2.9%
5Y-$357.99M+2.9%
All-$357.99M+2.9%

Cash From Operations History

YearValueChange
-$347.69M+2.9%
-$357.99M-46.3%
-$244.72M-15.8%
-$211.39M-150.8%
$416.15M+374.6%
YearValueChange
-$151.58M-402.5%
$50.12M+165.4%
-$76.64M-6.6%
-$71.91M-377.7%
-$15.05M-

FAQ

  • What is the current annual cash from operations of DNLI?

    As of today, DNLI annual cash from operations is -$347.69M

  • What is 1-year change in DNLI annual cash from operations?

    DNLI annual cash from operations is up +2.88% year-over-year

  • What is 3-year change in DNLI annual cash from operations?

    DNLI annual cash from operations is down -64.48% over the past 3 years

  • How far is DNLI annual cash from operations from its all-time high?

    DNLI annual cash from operations is currently -183.55% below its historical high of $416.15M set on December 31, 2020

  • How does DNLI annual cash from operations rank versus sector peers?

    DNLI annual cash from operations is higher than 1.78% of companies in Healthcare sector

  • When is DNLI next annual earnings release?

    The next annual earnings release for DNLI is on

Cash From Operations Formula

CFO = + Non Cash Expenses + Changes In

Data Sources & References

  1. DNLI Official Website www.denalitherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1714899/000171489925000193/0001714899-25-000193-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1714899/000171489925000066/0001714899-25-000066-index.htm
  4. DNLI Profile on Yahoo Finance finance.yahoo.com/quote/DNLI
  5. DNLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnli